News

The only sure way to ensure that sponsors can ensure their clinical trial protocols are truly patient-centric is to design that focus into the protocol from the start, using a protocol optimization method such as Pro-ficiency’s Pro-Active Protocol solution.

Decentralized clinical trials (DCTs), including hybrid studies, have become the latest trend in pursuit of more patient-centric trials. But the full value of DCT methods and technologies may be dependent upon specific patient characteristics and individual site capabilities. Rather than assuming that use of DCT methods is beneficial to all patients, for instance, sponsors and research sites might do better to look closely at their specific patient cohorts to determine what individuals in those groups truly need.